These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 4139981

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. High incidence of elevated antibody titers to Epstein-Barr virus in patients with uveitis.
    Touge C, Agawa H, Sairenji T, Inoue Y.
    Arch Virol; 2006 May; 151(5):895-903. PubMed ID: 16362642
    [Abstract] [Full Text] [Related]

  • 23. Detection of Epstein-Barr virus DNA in American Burkitt's lymphoma.
    Ziegler JL, AnderssonM, Klein G, Henle W.
    Int J Cancer; 1976 Jun 15; 17(6):701-6. PubMed ID: 181331
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT, Freeman CB, Pizzo P, Gadek J, Jaffe E, Santaella M, Hammer C, Frank M, Reaman G, Novikovs L.
    J Natl Cancer Inst; 1980 Mar 15; 64(3):477-83. PubMed ID: 6243722
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Elevated Epstein-Barr virus antibodies in patients with Hodgkin's disease].
    Kuljić-Kapulica N.
    Srp Arh Celok Lek; 1998 Mar 15; 126(3-4):97-100. PubMed ID: 9863363
    [Abstract] [Full Text] [Related]

  • 32. Comparison of immunofluorescence assay and multiplexed microparticle-based immunoassay for detecting Epstein-Barr virus viral capsid antigen antibodies.
    Zeytinoglu A, Altuglu I, Karatas E, Yazan Sertoz R.
    J Virol Methods; 2008 Mar 15; 148(1-2):300-2. PubMed ID: 18215427
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Epstein-Barr virus infection in heart and heart-lung transplant recipients: incidence and clinical impact.
    Gray J, Wreghitt TG, Pavel P, Smyth RL, Parameshwar J, Stewart S, Cary N, Large S, Wallwork J.
    J Heart Lung Transplant; 1995 Mar 15; 14(4):640-6. PubMed ID: 7578169
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G, Hewetson J, Henle W.
    Int J Cancer; 1973 May 15; 11(3):637-47. PubMed ID: 4364719
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Immunological characterization of Hodgkin's and non-Hodgkin's lymphoma patients with high antibody titers against Epstein-Barr virus-associated antigens.
    Masucci G, Mellstedt H, Masucci MG, Szigeti R, Ernberg I, Björkholm M, Tsukuda K, Henle G, Henle W, Pearson G.
    Cancer Res; 1984 Mar 15; 44(3):1288-300. PubMed ID: 6318984
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.